NASDAQ : AKTS

Aktis Oncology, Inc. — Earnings Estimates

$24.21 USD

$0.32 (1.34%)

Volume
257.1K
Average Volume
344.8K
Market Capitalization
$1.29B
P/E Ratio
-39.69
Dividend Yield
0.00%
Price Target
$35.00
Year High
$34.19
Year Low
$14.72
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$19.49

Annual earnings financials

AKTS financial data with annual/quarterly toggle

AKTS GAAP EPS - Annual & Quarterly

AKTS Sales Revenue - Annual & Quarterly

AKTS Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

AKTS Estimated and Actual Revenue by Quarter
AKTS Estimated and Actual EPS by Quarter
AKTS Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 2 - - - - - -
2028-09-30 1 - - - - - -
2028-06-30 1 - - - - - -
2028-03-31 2 - - - - - -
2027-12-31 3 - - - - - -
2027-09-30 2 - - - - - -
AKTS Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 2 -56.33M -41.98M -51.45M 3.72M 4.64M 4.33M
2028-09-30 1 -56.89M -42.4M -51.96M 3.72M 4.64M 4.33M
2028-06-30 1 -54.05M -40.28M -49.37M 3.72M 4.64M 4.33M
2028-03-31 2 -54.59M -40.68M -49.86M 3.72M 4.64M 4.33M
2027-12-31 3 -39.03M -29.09M -35.65M 2.48M 3.1M 2.89M
2027-09-30 2 -38.13M -28.41M -34.82M 2.48M 3.1M 2.89M
AKTS Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 2 1.29M 1.61M 1.5M 2 -1.01909 -0.75942 -0.9308
2028-09-30 1 1.29M 1.61M 1.5M 2 -1.02927 -0.76701 -0.9401
2028-06-30 1 1.29M 1.61M 1.5M 2 -0.97781 -0.72866 -0.8931
2028-03-31 2 1.29M 1.61M 1.5M 2 -0.98755 -0.73592 -0.902
2027-12-31 3 858.37K 1.07M 1M 1 -0.70618 -0.52624 -0.645
2027-09-30 2 858.37K 1.07M 1M 1 -0.68976 -0.514 -0.63